Healthcare

No items to show

ABL Health

Acted as lead financial advisor to the shareholders of ABL Healt on its sale to Bay Tree PE

May 2024
Not disclosed

Forest Healthcare

Advised the shareholders of Forest Healthcare on the sale of the business to Sculptor Capital Management

February 2024
Not disclosed

Invivo Clinical

Advised the shareholders of Invivo Clinical on its sale to Microba Life Sciences

December 2023
£11m

Metabolic Healthcare (T/A Lloyds Direct)

Acted as lead financial advisor to the shareholders of Metabolic Healthcare on the sale of the business to Pharmacy2U

October 2023
Not Disclosed

One Healthcare Partners

Acted as lead financial advisor to One Healthcare on the sale of its One Ashford and One Hatfield Hospitals to Phoenix Hospital Group

September 2023
Not Disclosed

Aesthetic Technology

Acted as lead financial advisor for Aesthetic Technology on the sale of the business to Omni Partners

January 2023
Not disclosed

Spire Healthcare Group plc

Advised Spire Healthcare Group plc on its acquisition of The Doctors Clinic Group

December 2022
£12m

Herida Medical

Acted as lead financial advisor to the shareholders of Herida Medical on the sale of the business to Winncare Group.

November 2022
Not disclosed

Nuffield Health

Advised Nuffield Health on its refinancing, comprising an ESG linked bank facilities and long leasehold financing

October 2022
£500m

Sigma Pharmaceuticals plc

Advised Sigma Pharmaceuticals plc on the refinancing of its Asset Based Facilities

October 2022
£45m

Rephine

Acted as lead advisor to Kester Capital LLP on its acquisition of iX Group (Rephine)

October 2021
Not disclosed

Robinson Healthcare

Acted as lead financial advisor to Robinson Healthcare Limited on the sale of the business to HIG-backed Vernacare

March 2021
Not disclosed

CHS Healthcare

Acted as lead financial advisor to CHS Healthcare Holdings on the sale of the business to Acacium Group who are backed by the private equity house Onex

February 2021
Not disclosed

Arcinova

Acted as financial advisor to BGF on the sale of Arcinova to Quotient

February 2021
Not disclosed

Renal Services UK

Acted as financial advisor to The Business Growth Fund and shareholders of Renal Services UK Limited on the sale of the business to DaVita Inc.

December 2020
Not disclosed

Bespoke Health & Social Care

Acted as lead advisors to Bespoke Health & Social Care on its sale to Westbridge Fund Managers

June 2020
Undisclosed

Fishawack Health

Acted as financial advisor to Fishawack Health on its acquisition of Skysis

April 2020
Undisclosed

Fishawack Health

Acted as financial advisor to the shareholders of Fishawack Health on the sale of the business to Bridgepoint

April 2020
Undisclosed

Medical Equipment Solutions

Acted as exclusive financial advisor to Medical Equipment Solutions on the sale of the business to Amethyst Radiograpy

March 2020
Undisclosed

ArchiMed

Acted as financial advisor to ArchiMed on the acquisition of Direct Healthcare Group

December 2019
Undisclosed

Sybos

Acted as independent advisor to the Trustees of Sybos on sale of NZ$338m stake in EBOS Group

November 2019
Undisclosed

Elis SA

Acted as lead financial advisor to Elis SA on the carve-out of its decontamination services business, IHSS, to VAMED AG

October 2019
Undisclosed

Cardinal Healthcare

Acted as financial advisor to Cardinal Healthcare on its disposal to Impact REIT plc and Optima Healthcare Limited

September 2019
£12.9 million

Horizon Care

Acted as financial advisor to Graphite Capital on its investment in Horizon Care

August 2019
Undisclosed

Elis SA

Acted as lead financial advisor to Elis SA on the disposal of its medical consumables division

July 2019
Undisclosed

Fishawack

Acted as financial advisor to Fishawack on its acquisition of 2e Group LLC

July 2019
Undisclosed

CARE Fertility

Acted as financial adviser to Bowmark Capital on the sale of CARE Fertility to Silverfleet Capital

May 2019
Undisclosed

Clyde Vet Group

Acted as financial advisor to Clyde Vet Group on its sale to VetPartners

May 2019
Undisclosed

Bowmark Capital of CARE

Acted as financing advisor to support the sale by Bowmark Capital of CARE Fertility to Silverfleet Capital

April 2019
£50m

The Good Care Group

Acted as financial advisor to The Good Care Group on the sale to Sodexo

April 2019
Undisclosed

Fishawack

Acted as financial advisor to Fishawack on its acquistion of Dudnyk

March 2019
Undisclosed

Sk:n

Advised Management on the sale of Sk:n to TriSpan Private Equity

February 2019
Undisclosed

Fishawack

Acted as financial advisor to Fishawack on its acquistion of Blue Latitude Health

December 2018
Undisclosed

Mangar Health

Acted as financial advisor to Mangar Health on the sale of the business to Winncare Group

December 2018
Undisclosed

Brian Dawn Veterinary Centre

Acted as financial advisor to Briar Dawn Veterinary Centre on the sale to CVS Group plc

October 2018
Undisclosed

Milewood Healthcare

Acted as financial advisor to the shareholders of Milewood (Holdings) Limited on its sale to BC8 SPRL

September 2018
Undisclosed

Origin

Acted as financial advisor to the shareholders of Origin Group on the sale of the business to VetPartners

July 2018
Undisclosed

Wear Referrals

Acted as financial advisor to Wear Referrals Limited on its sale to The Linnaeus Group

July 2018
Undisclosed

Fishawack

Acted as financial adviors to Fishawack on its acquisition of Healthcircle Advertising

July 2018
Undisclosed

Crawford Healthcare

Acted as financial advisor to the shareholders of Crawford Healthcare on the sale of the business to Acelity

June 2018
Undisclosed

White Cross Vets

Acted as financial advisor to White Cross Vets on the sale of the business to IVC

May 2018
Undisclosed

Willows Veterinary Group

Acted as financial advisor to the partners of The Willows Veterinary Group on the sale of the business to VetPartners

April 2018
Undisclosed

CHS Healthcare

Acted as financial adviser to the shareholders of CHS Healthcare on the minority sale of the business to Business Growth Fund

January 2018
Undisclosed

Synergy HCS

Acted as lead advisor to Synergy Health, a subsidiary of Steris plc, on the carve-out and sale of Healthcare Consumable Solutions to Verna Group

November 2017
Undisclosed

Porthaven

Acted as advisor to Phoenix Equity Partners on the sale of Porthaven Care Homes to Fremont Group

November 2017
Undisclosed

Clearwater Care

Acted as lead advisor to Synova Capital on the sale of Clearwater Care to Salutem Healthcare

November 2017
Undisclosed

Shaw Healthcare

Acted as financial advisor to Shaw Healthcare on the sale of a minority stake to Bridges Evergreen

November 2017
£10 million

Village Vet

Acted as lead advisor to the shareholders of Village Vet on its sale to Linnaeus Group

June 2017
Undisclosed

Biocomposites

Acted as lead advisor to the shareholders of Biocomposites on its sale to TA Associates

May 2017
Undisclosed

Prometheus Surgical

Acted as lead advisor to the shareholders of Prometheus on its sale to UK peer

May 2017
Undisclosed

Newbridge Care Systems Limited

Acted as lead advisor to the shareholders of Newbridge on its sale to Schoen Klinik

May 2017
Undisclosed

Steeper

Acted as lead advisor to Steeper on the sale of its bebionic assets to Otto Bock

February 2017
£31 million

Medivet

Acted as lead advisor including due diligence to Inflexion Private Equity on their minority investment in Medivet

February 2017
Undisclosed

Rayner Surgical

Acted as lead advisor to Phoenix Equity Partners on their minority investment in Rayner Surgical

January 2017
Undisclosed

Asquith Day Nurseries

Acted as financial advisor to the shareholders of Asquith Day Nurseries on the sale of the business to Bright Horizons Family Solutions

November 2016
£166 million

Assura Group

Acted as financing advisor in relation to numerous financings including a £200m unsecured RCF and £100m private placement

May 2016
£300m

For more information on deals in the Healthcare sector, please contact Andrew Nicholson.